Paracrine/autocrine regulation of breast cancer by the insulin-like growth factors
- 1 February 1998
- journal article
- review article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 47 (3) , 219-233
- https://doi.org/10.1023/a:1005903000777
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- Thrombospondin and transforming growth factor-beta 1 increase expression of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in human MDA-MB-231 breast cancer cellsCancer, 1995
- Expression of insulin-like growth factor I (IGF-I) in female breast cancer as related to established prognostic factors and long-term prognosisEuropean Journal Of Cancer, 1995
- Processing of insulin-like growth factor-II (IGF-II) by human breast cancer cellsMolecular and Cellular Endocrinology, 1994
- Effect of endocrine therapy on growth of T61 human breast cancer xenografts is directly correlated to a specific down-regulation of insulin-like growth factor II (IGF-II)European Journal Of Cancer, 1993
- Transforming growth factor‐β1 stimulates macrophage urokinase expression and release of matrix‐bound basic fibroblast growth factorJournal of Cellular Physiology, 1993
- Tamoxifen reduces serum insulin-like growth factor I (IGF-I)Breast Cancer Research and Treatment, 1992
- Expression of IGF-I and IGF-II mRNA in breast tissueBreast Cancer Research and Treatment, 1992
- Cathepsin D and Prognosis in Breast CancerNew England Journal of Medicine, 1990
- Effects of human breast fibroblasts on growth and 17β-estradiol dehydrogenase activity of MCF-7 cells in cultureBreast Cancer Research and Treatment, 1988
- Abnormal properties of skin fibroblasts from patients with breast cancerInternational Journal of Cancer, 1984